Antidiabetic role of high density lipoproteins
Authors:
- 1 November 2018
- journal article
- Published by Institute of Biochemistry in Biomeditsinskaya Khimiya
- Vol. 64 (6) , 463-471
Abstract
Disturbance in lipid metabolism can be both a cause and a consequence of the development of diabetes mellitus (DM). One of the most informative indicator of lipid metabolism is the ratio of atherogenic and antiatherogenic fractions of lipoproteins and their protein components. The review summarizes literature data and own results indicating the important role of high-density lipoprotein (HDL) and their main protein component, apolipoprotein A-I (apoA-I), in the pathogenesis of type 2 DM. On the one hand, HDL are involved in the regulation of insulin secretion by b-cells and insulin-independent absorption of glucose. On the other hand, insulin resistance and hyperglycemia lead to a decrease in HDL levels and cause modification of their protein component. In addition, HDL, possessing anti-inflammatory and mitogenic properties, provide anti-diabetic protection through systemic mechanisms. Thus, maintaining a high concentration of HDL and apoA-I in blood plasma and preventing their modification are important issues in the context of prevention and treatment of diabetes.Keywords
This publication has 72 references indexed in Scilit:
- The association between the apolipoprotein A1/ high density lipoprotein -cholesterol and diabetes in Taiwan — a cross-sectional studyBMC Endocrine Disorders, 2013
- Apolipoprotein A-IV improves glucose homeostasis by enhancing insulin secretionProceedings of the National Academy of Sciences, 2012
- HDLs Protect Pancreatic β-Cells Against ER Stress by Restoring Protein Folding and TraffickingDiabetes, 2012
- Serum Apolipoprotein AI and B Are Stronger Biomarkers of Diabetic Retinopathy Than Traditional LipidsDiabetes Care, 2011
- High density lipoprotein: it's not just about lipid transport anymoreTrends in Endocrinology & Metabolism, 2011
- Cholesterol efflux to apoA-I in ABCA1-expressing cells is regulated by Ca2+-dependent calcineurin signalingJournal of Lipid Research, 2010
- Dysfunctional HDL as a Diagnostic and Therapeutic TargetArteriosclerosis, Thrombosis, and Vascular Biology, 2010
- Poor Glycemic Control Is an Independent Risk Factor for Low HDL Cholesterol in Patients With Type 2 DiabetesDiabetes Care, 2009
- Hyperglycaemic conditions decrease cultured keratinocyte mobility: implications for impaired wound healing in patients with diabetesBritish Journal of Dermatology, 2008
- Reconstituted HDL infusion restores endothelial function in patients with type 2 diabetes mellitusDiabetologia, 2008